← Open Payments lookup

SUSAN TOMPKINS: Open Payments

NPI 1245266881 · LUVERNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$600 in 32 payments from 13 companies in 2025. Trend: 2023 $798 · 2024 $1,005 · 2025 $600

Food & beverage: $600
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$108
ABBVIE INC.5$105
GlaxoSmithKline, LLC.4$73
Novo Nordisk Inc4$73
Otsuka America Pharmaceutical, Inc.3$57
Neurocrine BioSciences, Inc.2$41
Phathom Pharmaceuticals, Inc.2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Lundbeck LLC1$22
Ardelyx, Inc.1$18

Products named: VRAYLAR, REXULTI, TRELEGY ELLIPTA, BREZTRI, Ozempic, INGREZZA, VOQUEZNA, XIFAXAN.

Industry payments across AL — which companies pay providers there.